Recent Articles from GlobeNewswire

Mr. Rooter Plumbing® shares tips to help homeowners avoid drain issues

Faster processing, deeper insights, and seamless integration — MediaViz AI empowers businesses to transform media into actionable intelligence

Nokia CorporationStock Exchange Release29 April 2025 at 15.45 EESTResolutions of Nokia Corporation’s Annual General MeetingEspoo, Finland – The Annual General Meeting (AGM) of Nokia Corporation took place today 29 April 2025 in Helsinki, Finland. The AGM approved all the proposals of the Board of Directors to the AGM. The AGM adopted the Company’s financial statements, discharged the members of the Board and the President and Chief Executive Officer from liability for the financial year 2024 and adopted the Company’s Remuneration Report and Remuneration Policy. In addition, the AGM adopted the following resolutions.Authorization to the Board to decide on the asset distribution The AGM decided that no dividend is distributed by a resolution of the Annual General Meeting and authorized the Board to resolve on the distribution of an aggregate maximum of EUR 0.14 per share as dividend from the retained earnings and/or as assets from the reserve for invested unrestricted equity.The authorization is valid until the opening of the next Annual General Meeting. The Board will resolve separately on the amount and timing of each distribution of the dividend and/or assets from the reserve for invested unrestricted equity so that the preliminary record and payment dates will be as set out below. The Company shall make a separate announcement of each such Board resolution confirming the relevant record and payment dates. Preliminary record dates    Preliminary payment dates

PALM BEACH, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come. According to Metastat, Global AI in Diabetic Retinopathy Market is witnessing unprecedented growth, reshaping the landscape of diagnostic and therapeutic interventions for this prevalent and sight-threatening complication of diabetes. As technology continues to advance, artificial intelligence (AI) is emerging as a transformative force in healthcare, particularly in the domain of diabetic retinopathy (DR), where early detection and timely intervention are critical. The report said “AI applications in diabetic retinopathy are gaining momentum due to their ability to augment traditional diagnostic methods. Image analysis, a cornerstone in the detection of retinal abnormalities, has witnessed a paradigm shift with the incorporation of AI algorithms. These algorithms, trained on vast datasets of retinal images, demonstrate remarkable accuracy in identifying subtle changes indicative of diabetic retinopathy. Consequently, they empower healthcare professionals with more efficient and precise tools for early diagnosis. One of the notable contributions of AI in diabetic retinopathy lies in its potential to address the challenge of limited access to ophthalmic expertise, especially in resource-constrained regions. Automated screening processes, driven by AI, enable remote and quick assessment of retinal images, offering a scalable solution to bridge the gap in healthcare accessibility. This democratization of expertise has the potential to revolutionize the way diabetic retinopathy is diagnosed and managed globally.” According to a report issued by Grand View Research: “the global diabetic retinopathy market size was estimated at USD $9.48 Billion in 2024 and is expected to grow at a CAGR of 6.4% from 2025 to 2030. One of the main factors expected to fuel market expansion is the growing incidence of diabetes in older individuals and the rising prevalence of blindness caused by diabetes. The introduction of novel diagnostic technologies and treatments and the increased awareness are driving the market expansion.”   Active healthcare/tech companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Recursion (NASDAQ: RXRX), Tempus AI, Inc. (NASDAQ: TEM), Predictive Oncology Inc. (NASDAQ: POAI), ADMA Biologics, Inc. (NASDAQ: ADMA).

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’Dwyer, who lived with myeloma for 18 years until he peacefully passed this Sunday, April 27, surrounded by family and friends.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (TMC or the Company), an explorer of the world’s largest undeveloped resource of critical metals for infrastructure, defense, energy and future technologies, today announced that its U.S. subsidiary, The Metals Company USA LLC (TMC USA), has submitted applications for a commercial recovery permit and two exploration licenses under the Deep Seabed Hard Mineral Resources Act (DSHMRA) and National Oceanic and Atmospheric Administration (NOAA) implementing regulations which form the U.S. seabed mining code.

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH), a one-stop-shop property technology platform offering end-to-end real estate solutions including brokerage, renovation, and condominium property management services in Singapore, today announced its audited financial results for the fiscal year ended December 31, 2024.

“Positioning the Company to Meet Rising Regional Demand”

Former Mortgage Loan Officer Turned PGA TOUR Champion Embodies Helport AI’s Mission to Empower Excellence

MAYFIELD VILLAGE, OHIO, April 29, 2025 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, May 6, 2025, beginning at 9:30 a.m. eastern time. This quarterly call, which will consist of both a conference call and audio-only webcast, is scheduled to last 60 minutes and will consist of a question-and-answer session with Tricia Griffith, our CEO, and John Sauerland, our CFO. Call-in participants will be able to ask questions via phone, however, webcast participants will not be able to submit questions online.

Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in attendance

COCONUT CREEK, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, today announced the closing of three Japanese operating lease with call option (“JOLCO”) transactions, totaling US$64.8 million in financing. Two of the loans closed in the first quarter of 2025 for a PW1127GA-JM engine and a PW1133G-JM engine, respectively, and mature in 2033. The third loan closed in April of 2025 for a LEAP-1A engine and matures in 2034. These transactions bring WLFC’s total JOLCO financings to approximately US$119.8 million.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand, announced today that the company will release its first quarter 2025 results before the market opens on Friday, May 9, 2025, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company’s results and business outlook.

Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024

Vancouver, BC, April 29, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that partner company Terra Clean Energy Corp. (“Terra”, previously Tisdale Clean Energy) announces an upcoming summer drill program at the South Falcon East Uranium Project (the “Property”) which hosts the Fraser Lakes B Uranium Deposit. The Property lies 18 km outside the edge of the Athabasca Basin, approximately 50 km east of the Key Lake Uranium Mill and former mine. Skyharbour optioned the Project to Terra and under the Option Agreement assuming the 75% interest is earned, Terra will fund exploration expenditures totaling CAD $10,500,000, as well as pay Skyharbour CAD $11,100,000 in cash of which $6,500,000 can be settled for shares in the capital of Terra (“Shares”) over the earn-in period.

SYDNEY, April 29, 2025 (GLOBE NEWSWIRE) -- Brazilian Rare Earths Limited (ASX:BRE / OTCQX: BRELY) (‘BRE’) presents its quarterly report for the period ended 31 March 2025. Key highlights during and subsequent to the end of the quarter included:

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- The Texas Space Commission has selected Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”) (“Company”), a leading space technology, infrastructure, and services company, for a grant up to $10 million from the Space Exploration and Research Fund (“SEARF”). This funding supports the development of an Earth reentry vehicle and orbital fabrication lab designed to enable microgravity biomanufacturing and is intended to serve as a critical risk-reduction platform for the Company’s future lunar sample return missions.

SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s first quarter 2025 financial results on Tuesday, May 6, 2025, before the open of the U.S. financial markets.

WASHINGTON, April 29, 2025 (GLOBE NEWSWIRE) -- Verizon today announced the launch of its first Government Cloud-Managed Software Defined Wide Area Network (SD WAN) product. Built on Verizon’s Federal Risk and Authorization Management Program (FedRAMP) High Ready Government Cloud Platform for U.S. federal agencies, the new offering is highlighted by the platform’s first SaaS Managed SD WAN solution. This innovative offering, already FedRAMP High Ready and built to NIST 800-53 controls, provides Federal agencies with a secure, scalable, and modernized network infrastructure tailored to meet their unique network and connectivity requirements.

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. ("Primech AI" or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced its strategic entry into the European market through a Memorandum of Understanding (MOU) with TCOrobotics GmbH, establishing a distribution framework for its innovative HYTRON, AI-powered autonomous bathroom cleaning robots across Germany, Austria, and Switzerland (DACH region).

MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first fiscal quarter ended March 31, 2025 on Friday, May 9, 2025 before the market opens.

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Monday, May 12, 2025, at 5:00 p.m. Eastern Daylight Time (EDT) to discuss its financial results for the first quarter ended March 31, 2025. The Company’s results will be reported in a press release prior to the call.

FORT MYERS, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the second quarter ended March 31, 2025, on Tuesday, May 13, 2025 after market close.

Momentum Continues with Added Stores at Major Retailer

Collaboration aims to use FYR’s AI-enabled EV-Omics (EVO) platform to produce dynamic, real-time insights into Parkinson’s disease

ROCHESTER, NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced that Tom Lopa has joined the company as Director of Opto-Mechanicals. Mr. Lopa brings extensive experience in manufacturing operations, strategic leadership, and manufacturing process optimization to Syntec Optics.

See the Future of AI for Behavioral Health (Qualifacts® iQ) at NatCon25 Booth #201.

Award demonstrates Cycurion’s growth in public, transportation sector through comprehensive IT and cybersecurity services offering

The hire of Holly Brown as CRO positions PTR for accelerated growth and innovation in the equipment rental space.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

MORRISTOWN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Schindler Elevator Corporation, a leading provider of elevators, escalators and moving walks, announces the launch of the Schindler 5000 – a machine-room-less (MRL) elevator designed for low- to mid-rise offices, hotels, hospitals, apartment complexes, and more.

Investing in Billion-Dollar B2B Distributors to Become the Leader by Harnessing AI

Independent Hotel Brand Strengthens its Global Portfolio in Q1

Mix and Match Menu Offers Variety and Value of Fan Favorites and New Items

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced its financial results for the fourth quarter and full year ended December 31, 2024.

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025.

BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, has entered into a technology partnership with UK-based EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalized treatments for cancer, cardiovascular and infectious diseases.

MCDONALD, Tenn., April 29, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, today announced the Company signed a five-year, exclusive supply agreement with Velo3D, Inc. (OTC:VLDX) (“Velo3D”), a leading U.S. based, metal additive manufacturing technology company for mission-critical parts in the defense, space, and aviation industries.

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (Nasdaq: CSWI) (the “Company”) today announced that the Company will transfer the listing and trading of its common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”).

SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Atsign, a pioneer in security through invisibility solutions, and S-IMSY, a leading provider of innovative SIM-based connectivity solutions, today announced a strategic partnership to deliver a comprehensive, secure, and cost-effective solution for remote IoT device management. This collaboration addresses the growing need for robust security in IoT deployments, particularly in industrial and enterprise settings where traditional networking solutions often fall short.

Juve Stabia’s next two Serie B fixtures will be streamed live and free in the United States, Canada and United Kingdom, further advancing Brera Holdings and the Club’s growing global profile

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will give two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 4–8, 2025, in Salt Lake City, Utah. The presentations will highlight baseline patient characteristics from the ongoing DRAGON trial and pharmacokinetic and pharmacodynamic properties from the ongoing DRAGON II trial, both in Stargardt disease.

BARCELONA, Spain, April 29, 2025 (GLOBE NEWSWIRE) -- Miller Tanner Associates (MTA), a leader in global event operations for 28 years, today announced from the Outsourcing in Clinical Trials Europe 2025 conference in Barcelona, Spain, that it has restructured operational hubs in the Americas, EMEA, and Asia-Pacific regions. This strategic initiative furthers MTA’s commitment to providing exceptional international support to its pharmaceutical, biotechnology, and medical device customers. The restructuring aligns with MTA’s mission to deliver impactful events that meet the diverse and evolving needs of its global customers.

Ogden, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- Becklar Monitoring was thrilled to be recognized by The Monitoring Association (TMA) with two prestigious honors in the recent TMA 2025 Monitoring Center Excellence Awards celebration.  

WATERTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will host a virtual KOL investor event on Friday, May 9 at 1:00 PM ET / 10:00 AM PT to provide an overview of anemia of myelofibrosis (MF) and discuss the evolving treatment landscape for this disease. The event will also include an overview of Disc’s clinical data and development plans for DISC-0974 in MF anemia.

Swiss AI startup's new smart data collection solution LightlyEdge enables European automotive manufacturers to close the innovation gap with smarter, faster data collection deployed directly in vehicles.

Leading cybersecurity services firm to train its team on authID’s biometric authentication and verification platforms, aiming to accelerate the adoption of secure and privacy-preserving passwordless solutions.

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for its 13-week third fiscal quarter ended March 29, 2025.

WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the appointment of Merdad Parsey, M.D., Ph.D. to the company’s board of directors.

Since joining the VC firm, Keshia and BDev Ventures have invested in over 50 startups, with 25% achieving markups.

LONG BEACH, Calif. and TORONTO, April 29, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announced that it will report financial results for the first quarter 2025 ended March 31, 2025, on Tuesday, May 13, 2025, after market close. The Company will host a conference call to discuss the results at 5:00 p.m. Eastern Time.

Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ: SANA) and certain officers.  The class action, filed in the United States District Court for the Western District of Washington, and docketed under 25-cv-00512, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against Sana and certain of its top officials.

New features help developers and security teams block risk early, from open source packages to AI models and containers

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) and certain officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-01877, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEWPORT BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the filing of four novel patent applications for its two candidates EL-22 and EL-32. These patent applications cover the animal market, as well as treating muscle loss in obese patients, both as standalone and combination therapies alongside GLP-1 receptor agonists.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQ: FLNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

CALGARY, Alberta, April 29, 2025 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it will release its first quarter 2025 financial results on Wednesday, May 7, 2025, after markets close.

Ecommerce leaders honor the most innovative customers and agency and technology partners for their work pushing ecommerce boundaries to new levels of success

MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the appointment Hui Liu as Director of Biostatistics.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain officers.  The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02563, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Geron securities between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2025.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or the “Company”) (NASDAQ: CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey,  and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 13, 2025, to review first-quarter 2025 results.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NET Power Inc. ("Net Power" or the "Company") (NYSE:NPWR) and certain officers. The class action, filed in the United States District Court for the Middle District of North Carolina, and docketed under 25-cv-00296, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Net Power securities between June 9, 2023 and March 7, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSE: ELF) and certain officers.  The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02316, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Elf securities between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Reflecting Mark43 and Flock Safety’s shared commitment to interoperable public safety platforms, this partnership will allow law enforcement to benefit from streamlined operations by integrating CAD, RMS, and Flock LPR and video data

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

WILMETTE, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that data on the long term efficacy and safety of its ALXN1840 (tiomolybdate choline) drug candidate for Wilson disease has been accepted for a late-breaker poster presentation at the European Association for the Study of the Liver (“EASL”) International Liver Congress 2025. EASL is recognized as one of the premier events in the hepatology space and will be held in Amsterdam, Netherlands from May 7 – 10, 2025.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TFI International Inc. (“TFI” or the “Company”) (NYSE: TFII). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

BRIDGEWATER, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, announced that it has entered into an agreement with TP Birch Grove to refinance its existing senior notes and term loan facilities with a new $200 million, four-year term loan, extending the maturity of its debt and further enhancing the Company’s financial flexibility.

Leading imaging source integration enhances access to comprehensive, interoperable data for life sciences research

WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today reminds that CEO Dr. Ryan Saadi MD, MPH will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be featured on the panel discussion titled Paths to Liquidity: Strategies for Adapting to a Volatile Market, moderated by David C Schwartz, Partner at Morgan Lewis. Along with Dr. Ryan Saadi, the panel will also include commentary from Matt Vamvakis, MBA, Managing Director, J.P. Morgan Private Bank, Amanda Laskey, Life Sciences Senior Analyst, RSM US, and Kee Colon, MBA, Managing Director, Cantor Fitzgerald.